Integrated bulk and single-cell RNA sequencing reveals a cuproptosis-related LncRNA prognostic signature in neuroblastoma
Our findings establish a novel prognostic framework for NB that enhances risk stratification accuracy and provides actionable biomarkers to guide precision clinical management.
Authors
- Wanjun Li (ORCID: https://orcid.org/0000-0003-4707-4288)
- Jun Xiao (ORCID: https://orcid.org/0000-0001-6472-1833)
- Jiexiong Feng (ORCID: https://orcid.org/0000-0001-9596-2330)
- Xinyao Meng (ORCID: https://orcid.org/0000-0002-3392-9049)
- Xuyong Chen (ORCID: https://orcid.org/0000-0001-5069-0896)
- Luyao Wu
- Jing Wang (ORCID: https://orcid.org/0000-0002-2512-0223)
- Ke Chen (ORCID: https://orcid.org/0000-0002-6914-6257)
- Xiang Zhao (ORCID: https://orcid.org/0000-0002-5332-4602)
- Zejian Li (ORCID: https://orcid.org/0000-0002-7039-0601)
- Shanshan Yang (ORCID: https://orcid.org/0000-0003-3729-7795)
Institutions
- Tongji Hospital (CN)
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1186/s12885-025-14463-8
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China